Reported Standalone quarterly numbers for Bal Pharma are:Net Sales at Rs 81.49 crore in December 2023 up 6.44% from Rs. 76.56 crore in December 2022.
Quarterly Net Profit at Rs. 1.26 crore in December 2023 down 14.49% from Rs. 1.47 crore in December 2022.
EBITDA stands at Rs. 7.88 crore in December 2023 up 11.3% from Rs. 7.08 crore in December 2022.
Bal Pharma EPS has decreased to Rs. 0.80 in December 2023 from Rs. 0.94 in December 2022.
| Bal Pharma shares closed at 118.50 on February 12, 2024 (NSE) and has given 25.13% returns over the last 6 months and 48.87% over the last 12 months. |
| Bal Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 81.49 | 92.30 | 76.56 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 81.49 | 92.30 | 76.56 | | EXPENDITURE | | Consumption of Raw Materials | 37.92 | 50.19 | 38.89 | | Purchase of Traded Goods | 1.67 | 3.38 | 3.84 | | Increase/Decrease in Stocks | 6.27 | -0.25 | 0.47 | | Power & Fuel | -- | -- | -- | | Employees Cost | 14.17 | 14.18 | 13.21 | | Depreciation | 2.55 | 2.02 | 2.03 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.84 | 17.14 | 13.85 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.08 | 5.64 | 4.28 | | Other Income | 0.26 | 0.41 | 0.77 | | P/L Before Int., Excpt. Items & Tax | 5.33 | 6.05 | 5.05 | | Interest | 3.66 | 3.82 | 3.12 | | P/L Before Exceptional Items & Tax | 1.67 | 2.23 | 1.93 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 1.67 | 2.23 | 1.93 | | Tax | 0.42 | 0.63 | 0.46 | | P/L After Tax from Ordinary Activities | 1.26 | 1.60 | 1.47 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.26 | 1.60 | 1.47 | | Equity Share Capital | 15.80 | 15.69 | 15.69 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.80 | 1.02 | 0.94 | | Diluted EPS | 0.80 | 1.02 | 0.95 | | EPS After Extra Ordinary | | Basic EPS | 0.80 | 1.02 | 0.94 | | Diluted EPS | 0.80 | 1.02 | 0.95 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
